 |
News Search |
 |
 |
 |
New Clinic Offers One-stop Shopping for All Your Cognitive Needs
|
 |
 |
|
 |
 |
16 March 2009. A new kind of cognitive clinic, which opened 6 March in Santa Barbara, California, aims to help people stay mentally sharp by addressing mind, body, and soul.
After three years of development, Cognitive Fitness and Innovative Therapies (CFIT) opened its doors to a pilot group of clients this month. CFIT (pronounced “see-fit”) will help not only people who have cognitive impairment or Alzheimer disease, but also advise mentally fit clients on how to remain that way for as long as possible. “It is a new way of thinking about the whole person for their cognitive health,” said Debra Lieberman, a communications researcher at the University of California, Santa Barbara (UCSB), who is developing a virtual community for CFIT users. “You are not just a patient with diagnoses; all aspects of your daily life come into play.”
Ken Kosik, a neurologist at UCSB and executive director of CFIT, envisions the center as a place where people concerned about Alzheimer’s can get all the information and services they require in one location. Kosik is best known for his basic research on presenilin (Lemere et al., 1996), tau (Kosik et al., 1986), and RNA interference (Krichevsky and Kosik, 2002). The CFIT project is an addition to his ongoing research at UCSB (see ARF related news story and interview with Ken Kosik). CFIT has services for people who already suffer from cognitive impairment, but Kosik is excited to also assist people at risk for Alzheimer’s in staving off its approach. “We focus on people who may get it, before they get it,” Kosik said.
Studies have shown that staying physically fit, eating right, challenging one’s mind, and being social can all benefit cognitive health. CFIT aims to apply those data by designing personalized lifestyle programs for each client. “Their ability to bring together the state-of-the-art information in all arenas is unique,” said Rhonda Spiegel, executive director of the Alzheimer’s Association Central Coast Chapter headquartered in Santa Barbara, who is not involved with CFIT.
The center should be a fun place to go, Kosik said, and he plans that clients will use it on a weekly basis. To make the setting inviting, CFIT has decorated its suite, just outside a local hospital, in living room style, with tan couches and black leather chairs, sculptures, and a fountain to create a cozy, less clinical atmosphere. Users will have access to age-appropriate exercise equipment, including a reclined elliptical trainer and a Wii Fit so they can move their feet to the tunes of “Dance Dance Revolution.” A nutritionist will help clients assess their diet and may recommend supplements. The center offers computers that members can use for mind fitness games, such as programs that ask the player to decide which of two sounds lasted longer, or quickly identify the first letter of the word for a picture flashed on the screen. Kosik will start with a small pilot group of approximately 20 clients, who will use the center while CFIT refines its services. CFIT could eventually serve 700 users, Kosik estimates.
Also on offer are services to enhance social relationships among users. The center will assemble groups of clients that use the facilities simultaneously, so they get to know each other. “When people get social support, and have a circle of friends, they stay healthier,” Lieberman said. She and others are assembling an online social networking interface that will work in conjunction with Facebook. Users will be able to log on and record their diet and exercise habits—then see how their activities compare to those of others in their social network. Studies have shown that keeping tabs on what others are doing can promote healthy lifestyles, Lieberman said. In addition, Lieberman hopes to archive records from the social network that clinicians can then mine for data on how well the interventions work.
Kosik has assembled a team including medical doctors, a nutritionist, a social worker, and a chaplain. A unique position at CFIT is that of “navigator.” Tonya Kydland, a cognitive psychologist with experience in genetics, will help CFIT clients sift through the vast amount of information, some of it conflicting or misleading, that is available on the Internet. She can also help people understand how markers in their DNA contribute to a risk for Alzheimer’s. Kydland will assist patients in finding clinical trials if they wish to participate in one. That kind of informational service is not routinely available in a physician’s office. “Doctors only have a certain amount of time,” Kydland said. “I can sit with a client for two hours, if we want to.”
CFIT also plans to nurture the spirit, if clients feel they need it. Michelle Woodhouse, an Episcopal priest, described herself as the “director of spiritual care.” She will be available to counsel members of any faith, or no religion at all, on how to enrich their lives. “I’m interested in what are the important relationships in this person’s life.” she said. “Are there ways that an older person can enhance their quality of life?” That enhancement could take many forms: re-establishing a personal religion, reaching out to friends more, or finally planning that trip to Tuscany. Woodhouse can also help people plan end-of-life care and express their desires for a funeral service.
CFIT is partnering with community organizations, such as Life Chronicles, a Santa Barbara-based nonprofit that produces “memory” videos of people with terminal illnesses. A family may want a video, for example, to preserve a loved one’s character, spirit, and stories before a cognitive condition makes it hard for them to remember or communicate. In addition, such videos could be useful for professional caregivers who may not meet their patient until the person needs constant assistance. “Inside there’s still this person; you just can’t reach them anymore,” said Kate Carter, president of Life Chronicles. Viewing a memory video “helps the caregiver connect much better, which means better care no matter how you look at it,” she said.
The center will closely monitor the efficacy of its interventions, in order to measure if the approach works. While research studies typically focus on one particular intervention—following a Mediterranean diet, for example—Kosik and colleagues will analyze the effectiveness of CFIT’s recommendations as a whole. Kosik expects that people who follow the center’s guidance will, on average, maintain better cognitive health than a control group, including people from local assisted-living facilities, who don’t follow a program like CFIT’s.
It will be critical that CFIT show its model is cost-effective, Kosik said. For now, the center is funded by donations from the surrounding community. CFIT clients will have to pay for services—approximately $1,800 for an evaluation, and $4,000 for a year-long center “membership.” A high priority for Kosik is to show that the lifestyle intervention program lowers overall medical costs, and to seek additional funding so people who can’t afford the fees can still use the center. Armed with such data, he might even convince insurance companies to cover some costs in the future. “It’s very much my intention not to turn this into a boutique operation,” Kosik said.
If the program is proven effective, other communities could build similar centers. In addition, the CFIT model could be useful for other conditions, such as Parkinson disease. “This is the beginning of a major movement,” said Tom Harriman, chairman of the CFIT board.—Amber Dance.
|
 |
 |
 |
Comments on News and Primary Papers |
 |
  |
| |
Comment by: J. Lucy Boyd
|
 |
 |
Submitted 17 March 2009
|
Posted 8 April 2009
|
 |
 |
I very much look forward to hearing updates about the progress of the center. I hope they will be able to produce quantifiable data of improved outcomes - quality of life, lowered medical costs, delay in nursing home placements, etc. View all comments by J. Lucy Boyd
|
 |

|
| |
Comment by: Bruce Miller
|
 |
 |
Submitted 28 May 2010
|
Posted 2 June 2010
|
 |
 |
|
 |
 |
 |
Comments on Related News |
 |
  |
| |
Related News: Mediterranean Diet Slims Down Risk of AD
Comment by: Erik Jansson
|
 |
 |
Submitted 1 May 2006
|
Posted 3 May 2006
|
 |
 |
I recommend the Primary Papers
An interesting conclusion of the study is that the overall dietary pattern should have a greater effect on health than a single nutrient. The findings would suggest that while difficult to treat, AD may be significantly preventable in the U.S. (1). Colin Meyer's comment that silicic acid, present in fish and the skins of grapes, is a prevention factor is of note. Silicic acid is an aluminum chelator. Reduced aluminum-based food additives in the true Mediterranean diet may represent an additional factor in its effect, since many epidemiology studies find the metal to be a major risk factor (2). Folic acid, vitamin E, melatonin, and polyphenols presented in fresh food are also aluminum chelators (3).
References: 1. Jansson E. Alzheimer's disease is substantially preventable in the United States - review of risk factors, therapy, and the prospects for an expert software system, Med Hypothesis. 2005; 64: 960-967. Abstract
2. Rogers M, Simon D. A preliminary study of dietary aluminum and risk of Alzheimer's disease, Age and Ageing. 1999; 28: 205-9. Abstract
3. Additional review at www.deptplanetearth.com.
View all comments by Erik Jansson
|
 |

|
| |
Related News: Mediterranean Diet Slims Down Risk of AD
Comment by: P.F. Jennings
|
 |
 |
Submitted 3 May 2006
|
Posted 7 May 2006
|
 |
 |
To add to the point that Erik Jansson makes—that there is more to the "Mediterranean diet" than just oils and "lots of vegetables"—think about pastis. And this will just be one example among many kinds of food and drink which are different between Europe and the U.S.
Pastis is the "traditional anise-flavored French liqueur" whose ingredients include "artemisia, black pepper, cardamom, centaury, cinnamon, clove, melequeta pepper, sage, star anise, tonka bean, white pepper."
People do drink pastis quite frequently. The question may be, how much difference will those herbs and spices make—multiplied by the number of drinks over the space of an adult lifetime? And how much difference do all of the drinks (Fernet Branca, as another example) and all of the organ meats, and all of the cheeses, and all of the shellfish and seafood make?
There are quite a large number of differences between the diet of an average American today and the diet of someone in Italy or the south of France or Spain. Just attributing the differences to certain oils and a lot of...
Read more
To add to the point that Erik Jansson makes—that there is more to the "Mediterranean diet" than just oils and "lots of vegetables"—think about pastis. And this will just be one example among many kinds of food and drink which are different between Europe and the U.S.
Pastis is the "traditional anise-flavored French liqueur" whose ingredients include "artemisia, black pepper, cardamom, centaury, cinnamon, clove, melequeta pepper, sage, star anise, tonka bean, white pepper."
People do drink pastis quite frequently. The question may be, how much difference will those herbs and spices make—multiplied by the number of drinks over the space of an adult lifetime? And how much difference do all of the drinks (Fernet Branca, as another example) and all of the organ meats, and all of the cheeses, and all of the shellfish and seafood make?
There are quite a large number of differences between the diet of an average American today and the diet of someone in Italy or the south of France or Spain. Just attributing the differences to certain oils and a lot of vegetables doesn't begin to examine all of the differences that actually exist.
View all comments by P.F. Jennings
|
 |

|
| |
Related News: Mediterranean Diet Slims Down Risk of AD
Comment by: Steve Parker, M.D. (Disclosure)
|
 |
 |
Submitted 30 January 2009
|
Posted 5 February 2009
|
 |
 |
Fish consumption may be a determinant of the Mediterranean diet's prevention or amelioration of Alzheimer disease.
The protective fish seem to be cold-water, fatty fish such as trout, salmon, sardines, herring. The protective dose is about two servings of fish per week.
A study from 2007 also suggested prolongation of life in AD patients by adherence to a Mediterranean diet.
References: Scarmeas N, Luchsinger JA, Mayeux R, Stern Y. Mediterranean diet and Alzheimer disease mortality. Neurology. 2007 Sep 11;69(11):1084-93. Abstract
View all comments by Steve Parker, M.D.
|
 |

|
| |
Related News: Garbage BAG2 Takes Out the Tau
Comment by: Arthur Horwich
|
 |
 |
Submitted 26 February 2009
|
Posted 26 February 2009
|
 |
 |
This is an interesting set of results that seems to be suggesting that providing additional Bag2 somehow promotes a ubiquitin-independent proteasomal turnover of tau. I'm wondering how strongly expressed Bag2 might be in this context, relative to its basal level. Regardless, this is probing some interesting circuitry that deserves close attention. View all comments by Arthur Horwich
|
 |

|
| |
Related News: Garbage BAG2 Takes Out the Tau
Comment by: Chad Dickey
|
 |
 |
Submitted 28 February 2009
|
Posted 2 March 2009
|
 |
 |
I recommend the Primary Papers
This is a very informative paper from Carretierro et al. describing a novel relationship between BAG2 and tau. It further demonstrates the growing complexity of the chaperone network, moving us away from the idea that the chaperones are merely housekeeping genes that act in an unregulated, automated fashion. It seems that the route of tau clearance will be as complex, if not more complex, than the road to its hyperphosphorylation.
Members of the degradation process may also offer us more appropriate drug targets for therapeutic intervention in tauopathies and perhaps other diseases of protein misfolding. Identifying which chaperones are most specific for tau degradation could provide us with very novel clinical strategies for Alzheimer disease.
It should be noted that KNK437 does not inhibit Hsp70 activity but rather its levels via transcriptional repression of not only the Hsp70 gene, but also other heat shock genes (Yokota et al., 2000; Koishi et al., 2001). Changing the expression of Hsp70 levels could have very different consequences from directly inhibiting its...
Read more
This is a very informative paper from Carretierro et al. describing a novel relationship between BAG2 and tau. It further demonstrates the growing complexity of the chaperone network, moving us away from the idea that the chaperones are merely housekeeping genes that act in an unregulated, automated fashion. It seems that the route of tau clearance will be as complex, if not more complex, than the road to its hyperphosphorylation.
Members of the degradation process may also offer us more appropriate drug targets for therapeutic intervention in tauopathies and perhaps other diseases of protein misfolding. Identifying which chaperones are most specific for tau degradation could provide us with very novel clinical strategies for Alzheimer disease.
It should be noted that KNK437 does not inhibit Hsp70 activity but rather its levels via transcriptional repression of not only the Hsp70 gene, but also other heat shock genes (Yokota et al., 2000; Koishi et al., 2001). Changing the expression of Hsp70 levels could have very different consequences from directly inhibiting its ATPase function when clients are already bound.
One concern from many of these studies, including our own, is that the majority of models we work with overexpress tau. This is quite different from endogenous levels becoming dysfunctional, which is what occurs in human disease. It is quite possible that overexpressed chaperone clients, like tau, are processed quite differently from those that become dysfunctional at endogenous levels. Defining this could be critical for our understanding of the nature of chaperone biology in all protein misfolding diseases.
References: Yokota S, Kitahara M, Nagata K. Benzylidene lactam compound, KNK437, a novel inhibitor of acquisition of thermotolerance and heat shock protein induction in human colon carcinoma cells. Cancer Res. 2000 Jun 1;60(11):2942-8. Abstract
Koishi M, Yokota S, Mae T, Nishimura Y, Kanamori S, Horii N, Shibuya K, Sasai K, Hiraoka M. The effects of KNK437, a novel inhibitor of heat shock protein synthesis, on the acquisition of thermotolerance in a murine transplantable tumor in vivo. Clin Cancer Res. 2001 Jan;7(1):215-9. Abstract
View all comments by Chad Dickey
|
 |
 |
 |
| |
Submit a Comment on this News Article |
 |
 |
 |
 |
|